First study of SP-101 injection in healthy people
Part of Mental health clinical trials.
This early-stage study tests a new medication called SP-101, given as an intravenous (IV) infusion, in healthy volunteers to see if it is safe and how it is processed by the body. The goal is to find the best dose for future studies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 45 years old.
- You must be in good overall health, with no major active or chronic illnesses.
- You must have a body mass index (BMI) between 18 and 28 kg/m².
- You must be willing to use effective birth control and avoid donating sperm or eggs for 3 months after the last dose.
- You must not have taken any prescription or over-the-counter medications, herbal remedies, or supplements (except birth control pills) within 14 days before the study.
- You must have normal kidney function and lab test results, and no history of heart rhythm problems or significant blood donation recently.
- You must be willing to follow study procedures, including diet restrictions, and stay at the study site as required.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new investigational medicine in healthy adults to see how safe it is and how the body processes it. It is a first-in-human trial, so it is looking for volunteers who are generally well and have normal immune function.
This trial tests a new drug, GenSci136, in healthy adults to see if it's safe and how the body processes it. If you qualify, you would receive the drug and be monitored for side effects.
This is a first-in-human study of a new injected medication that may help with certain conditions. The trial is looking for healthy volunteers to check the drug's safety and how it works in the body.
This study tests a new investigational medicine called SSS67, given as a one-time IV infusion. It is an early-phase trial in healthy volunteers to check how safe the drug is and how the body handles it, and it may help researchers decide if it can be developed for future conditions.
This trial tests a new medicine called MT1011 given as an injection. Researchers want to see how safe it is and how the body handles it. Healthy people can join to help find the right dose for future studies.
This trial tests an investigational medication for adults with major depressive disorder who are currently taking an antidepressant but still have symptoms. It aims to see if adding this new drug can improve mood better than a placebo.
Hear when a new Major Depressive Disorder, Healthy Volunteer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.